4D Molecular Therapeutics, Inc.
FDMT
$6.65
$0.508.13%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -45.89% | -38.88% | 47.41% | 57.01% | 74.63% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -5.85% | 14.99% | 20.33% | 3.33% | 43.78% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -45.12% | -37.91% | 46.65% | 55.60% | 73.91% |
|
|
|||||
| Total Current Assets | -45.12% | -37.91% | 46.65% | 55.60% | 73.91% |
| Net Property, Plant & Equipment | 26.16% | 27.91% | 28.24% | 27.35% | -12.48% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 304.74% | 813.49% | 522.95% | 319.94% | 114.81% |
| Total Assets | -23.62% | -18.12% | 64.87% | 67.04% | 75.92% |
|
|
|||||
| Total Accounts Payable | 153.57% | -1.57% | 24.78% | -37.96% | -1.77% |
| Total Accrued Expenses | 50.20% | 79.77% | 57.06% | 110.07% | 94.25% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 79.01% | 78.98% | 79.01% | 62.86% | 3.00% |
| Total Finance Division Other Current Liabilities | -- | -- | -5.86% | -73.08% | -- |
| Total Other Current Liabilities | -- | -- | -5.86% | -73.08% | -- |
| Total Current Liabilities | 78.72% | 63.99% | 53.81% | 62.23% | 41.12% |
|
|
|||||
| Total Current Liabilities | 78.72% | 63.99% | 53.81% | 62.23% | 41.12% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 65.93% | 65.25% | 64.63% | 64.10% | -16.50% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -62.70% | -51.46% | 4.47% | 26.06% | 76.73% |
| Total Liabilities | 65.99% | 56.89% | 55.26% | 61.24% | 16.15% |
|
|
|||||
| Common Stock & APIC | 2.62% | 4.31% | 50.26% | 51.37% | 53.57% |
| Retained Earnings | -40.64% | -39.41% | -38.73% | -37.46% | -29.48% |
| Treasury Stock & Other | 215.02% | 404.59% | 1,331.25% | 102.06% | -184.93% |
| Total Common Equity | -28.46% | -21.79% | 65.87% | 67.59% | 80.95% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -28.46% | -21.79% | 65.87% | 67.59% | 80.95% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -28.46% | -21.79% | 65.87% | 67.59% | 80.95% |
|
|
|||||